You're contacting media contact of this press release

Title: CoreAge Rx Validates Effectiveness of Compounded GLP-1 Programs for Weight Management

United States, 19th Feb 2026– CoreAge Rx, a leading telehealth pharmacy specializing in compounded medications, announced today that its GLP-1 weight management programs are receiving widespread recognition for their effectiveness and accessibility. The announcement comes amid growing concerns over the high costs of brand-name weight loss medications and the increasing demand for patient-centric, affordable healthcare solutions.CoreAge Rx’s compounded GLP-1 programs are designed to provide the benefits of traditional therapies while offering a personalized and cost-effective approach. Patients have praised the programs not only for their results in weight management but also for the convenience and reliability of accessing medications through the company’s telehealth platform.“At CoreAge Rx, our mission is to transform healthcare accessibility and engagement,” said Ella Jones, spokesperson for CoreAge Rx. “Our telehealth platform allows individuals to receive premium, personalized medications in a hassle-free way. The positive feedback we’ve received from our patients reflects the real-world impact of our programs.”The telehealth model provided by CoreAge Rx ensures a seamless patient experience. Through the platform, patients can consult healthcare providers, manage prescriptions, and receive medications directly at home. This approach eliminates many traditional barriers, making it easier for individuals to manage their health and wellness goals.CoreAge Rx’s focus on compounded GLP-1 medications addresses a growing need in weight management and metabolic health. Compounded therapies are customized to the individual, enabling patients to receive treatments tailored to their specific requirements while maintaining affordability. This is particularly significant for...

This press release is issued by King Newswire